Urinary Tract Infections in Children - PowerPoint PPT Presentation

1 / 61
About This Presentation
Title:

Urinary Tract Infections in Children

Description:

Title: PowerPoint Presentation Last modified by: Authorised User Created Date: 1/1/1601 12:00:00 AM Document presentation format: On-screen Show Other titles – PowerPoint PPT presentation

Number of Views:840
Avg rating:3.0/5.0
Slides: 62
Provided by: sthelierv
Category:

less

Transcript and Presenter's Notes

Title: Urinary Tract Infections in Children


1
Urinary Tract Infections in Children
  • Dr. Rim El-Rifai
  • Consultant Paediatrician
  • QMHC

2
Outline of talk
  • Cases
  • Introduction and definitions
  • Evaluation of UTI
  • Management
  • Summary

3
7 year old girl
  • Initial referral to investigate secondary
    enuresis,
  • had a positive urine for UTI
  • Main concern nocturnal enuresis
  • Dysuria and dark offensive urine
  • History of PUOs for 2 days at a time
  • No abnormal physical findings on examination

4
investigations
  • Ultrasound scan KUB
  • Small capacity bladder, dilated distal ureter and
    urothelial thickening in Lt renal pelvis and
    large left kidney on USS
  • DMSA
  • left Duplex with scarring of upper pole- has
    patient had MCU?

5
3 weeks old girl
  • Initial presentation to AE vomiting
  • Treated with IV ABs
  • 2 urine samples had mixed growth but gt 100 WBC on
    SPA
  • FH brother had pyloric stenosis and UTI when 4
    mo old
  • TMP ran out after 2 weeks- did not get
    prescription

6
Investigations
  • KUB USS normal
  • Abdo. USS Pyloric Stenosis
  • MCUG and DMSA awaited

7
6 years old girl
  • Referred by GP for frequency and day time wetting
    at school
  • Urine showed no WBC but grew Enterococcus
  • treated as UTI with oral TMP
  • History frequency and urgency but not unwell or
    febrile
  • Further urine dipstick and KUB normal
  • On questioning urine collected in make shift jar
    at home

8
(No Transcript)
9
What is a UTI?
  • An inflammatory response of urothelium to
    bacterial invasion that is usually associated
    with bacteriuria and pyuria
  • i.e. MSU shows
  • WBC gt 10
  • Pure growth of organisms gt 107

10
Bacteriuria
  • Presence of bacteria in the urine in numbers
    exceeding the numbers caused by contamination
    from skin, urethra
  • Not a contaminant from the skin, vagina, prepuce
  • Collection technique sensitive
  • May be asymptomatic

11
Pyuria
  • Presence of white blood cells (WBCs) in the urine
  • Generally indicative of an inflammation of the
    urothelium as a response to bacterial invasion

12
Sites of origin of UTI
  • Acute pyelonephritis
  • acute bacterial infection of the kidney
  • Fever, rigors
  • Flank pain
  • Bacteriuria and pyuria
  • Unwell child, usually febrile

13
Sites of origin of UTI
  • Bacterial Cystitis Inflammation of the bladder
  • Abrupt onset of dysuria
  • Frequency
  • Urgency
  • Suprapubic pain
  • Non-bacterial cystitis chemical

14
Sites of origin of UTI
  • Urethritis
  • Inflammation of the urethra
  • Symptoms difficult to differentiate from cystitis
  • Seen in girls with vulvovaginitis

15
UTI in Childhood
  • Features commonly non-specific
  • Associated with anatomical Urological
    abnormalities
  • Difficulty in obtaining meaningful urine samples
  • Tendency to cause renal scarring
  • May lead to End Stage Renal Disease and
    Hypertension in adult life

16
UTI in Childhood
  • Always regarded as complicated
  • Treatment very effective
  • Recurrence is frequent following first UTI
  • 40 in females,
  • 32 in males

17
Childhood UTI Epidemiology
  • Prevalence is age and sex dependent
  • Overall F gt M
  • In 2-10 of children 2 mo 2 yrs of age with
    unexplained fevers

18
Incidence age
  • UTI diagnosed in 3 of prepubertal girls, and 1
    boys
  • In children less than 1 year
  • M (2.7) gt F (0.7)

19
Incidence sex
  • Most male infections under 3 months
  • 10 times more common in uncircumcised males
  • After first year 0.08 in boys
  • 3-4 in girls until 6 years
  • Up to 8 of girls are affected by UTI

20
Access of bacteria
  • Haematogenous spread with bacteraemia in first 12
    weeks
  • After 3 months by ascending seeding through
    urethra

21
Pathogens
  • Most common E. Coli
  • Other
  • Proteus spp (in boys)
  • Klebsiella
  • Pseudomonas
  • Enterococcus
  • Staphylococcus epidermidis
  • Staphylococcus aureus

22
Predisposing factors
23
Most commonly
  • Constipation
  • Vesico-ureteric reflux
  • Dysfunctional voiding- poor emptying
  • Infected periurethral area
  • Urinary stasis PUJ, VUJ obstruction
  • Ureteral duplication and ectopic ureters

24
Causes for recurrent UTI
  • Vesico-ureteric reflux
  • Urinary stasis, constipation
  • Infected periurethral area
  • Infected atrophic kidney
  • Ureteral duplication and ectopic ureters
  • Infected urachal cysts, infected ureteral stump
  • Foreign bodies
  • Stones

25
Vesico-Ureteric Reflux
26
Vesico-ureteric Reflux
  • VUR demonstrated in 1-2 of healthy children
  • More prevalent in infants and young children
  • An intermittent phenomenon
  • Increased detection rate due to antenatal
    screening
  • Can be provoked by elevated voiding pressures

27
Vesico-ureteric Reflux and UTI
  • Reported in 30-50 of children with UTI
  • A large number still present after their first
    UTI
  • Reflux nephropathy is the cause for end-stage
    renal failure in 3-25 of children and 10-15 of
    adults

28
Evaluation of UTI
29
Presentation/Evaluation
  • History in infants and toddlers
  • Fever,
  • irritability
  • Poor weight gain (FTT)
  • Smelly urine
  • Abdominal Pain
  • Dysuria, frequency, urgency
  • Haematuria
  • Enuresis and dysfunctional voiding
  • Constipation, thread worm infection, sore vulva

30
Presentation/Evaluation
  • History in children
  • Fever
  • Abdominal Pain
  • (Flank/loin pain)
  • Dysuria, frequency, urgency
  • Haematuria
  • smelly urine
  • Enuresis and dysfunctional voiding
  • Constipation, thread worm infection, sore vulva

31
History/ evaluation
  • History in Lower urinary tract infection
  • irritability
  • Abdominal Pain
  • Dysuria, frequency, urgency
  • Haematuria
  • smelly urine
  • Enuresis and dysfunctional voiding
  • Constipation, thread worm infection, sore vulva

32
History in enuresis/ incontinence
  • Nocturnal symptoms
  • Timing and onset of enuresis
  • Frequency of wetting (wet nights/week)
  • Times of wetting at night (one/several)
  • Amount of urine passed (small/large)
  • Daytime symptoms
  • Urinary frequency (frequent/infrequent)
  • Urgency and urge incontinence
  • Quality of stream
  • Complete emptying?
  • Posturing (Vincent curtsey)

33
Evaluation
  • Physical examination full examination including
  • Growth
  • BP
  • genitalia
  • Urine test
  • imaging

34
Neuropathic Bladder
Sacral Agenesis
35
Laboratory assessment
  • Urine dipstick for Nitrites, Leukocytes
  • Urinalysis (clean catch sample)
  • Direct microscopy and gram staining
  • Culture and sensitivities

36
AAP and RCPCH guidelines for diagnosis of UTI in
infants and young children
  • UTI should be ruled out in infants and children
    assessed to be sufficiently ill to require
    antibiotics treatment
  • Diagnosis of UTI requires a culture of urine

37
Imaging
38
Urinary Tract Imaging
  • Plain Abdominal x-ray
  • Ultrasound- any age
  • Micturating cystourethrogram lt 1 year
  • Nuclear Imaging- any age
  • IVU
  • CT scan

39
Ultrasound
  • Renal size and position
  • Scars, corticomedullary differentiation, cysts,
    masses, calcification, calculi
  • Pelvis and calyceal size and appearance
  • Pelvis-calyceal dilatation, urothelial thickening
  • Ureters
  • Dilatation, urothelial thickening, calculi
  • Bladder
  • outline, wall thickness, volume, residual volume

40
DMSA
  • Renal cortical morphology
  • Scars
  • Overall function
  • Differential function
  • No information on VUR

41
MAG 3
  • Quantify renal excretory function
  • Flow imaging
  • PUJ obstruction
  • Indirect cystogram

42
MCUG Bilateral VUR
DMSA Left renal scarring
43
Imaging of urinary tract after first febrile UTI
in Young children
  • USS during acute illness of limited value
  • MCUG useful in young age group where AB
    prophylaxis considered to reduce re-infection and
    renal scarring
  • DMSA at presentation and 6 months later
    identifies renal scarring

Pittsburgh SM N E J M, Jan 2003
44
Complications of UTI
45
Complications
  • Acute
  • Systemic illness, sepsis, renal abscess
  • Short term
  • Renal scarring, recurrence of UTI
  • Long term
  • Hypertension
  • End-stage renal disease (overall 0.5-5 of ESRD
    on dialysis have reflux nephropathy)

46
Renal scarring and VUR International Reflux
Study in Children
  • 5 yr follow up 302 patients (10 yrs in 5/8
    European centres)- serial IVU and DMSA
  • Grade III, IV, V VUR and symptomatic UTI
  • Medical vs Surgical treatment of VUR
  • New scars in 21 surgical and 19 medical
  • New scars mostly in children lt 5years old
  • New scars more frequent in Grade IV
  • New scars in 2 females gt 5 years
  • Olbing H et al, Ped Nephrol, Oct 2003

47
Complications of UTI in Children
  • Hypertension
  • Pyelonephritic scarring is the most common cause
    for hypertension in childhood
  • Prevalence of hypertension independent of the
    degree of scarring

48
Treatment
49
E. Coli Resistance trends
  • Ampicillin 39-45
  • Trimethoprim-sulfamethoxazole 14-31
  • Nitrofurantoin 1.8-16
  • Fluoroquinolones (Ciprofloxacin) 0.7-10
  • Mazzuli T, J Urol 2002

50
Drugs for Treatment
  • TMP 4 mg/kg BD for 7-10 days
  • Cephalosporins (Cefuroxime, Cephalexin)
  • Gentamicin
  • Ciprofloxacin
  • Ampicillin?
  • Nitrofurantoin (over 3 mon)?

51
Duration of treatment
  • Uncomplicated UTI gt 5 days is associated with
    higher cure rates
  • Tran D et al, meta-analysis of 1279 patients
  • J Pediatr 2001
  • In Children lt 2years of age 7-14 days
  • AAP, Pediatrics 1999 and RCPCH appraisal

52
Drugs for prophylaxis
  • Trimethoprim 2 mg/kg nocte
  • Cephalexin 12.5 mg/kg (up to 125 mg) nocte
  • Nitrofurantoin (over 3 mon) 1 mg/kg nocte

53
Cessation of prophylaxis
  • By age 4 years
  • When urinary continence achieved and infection
    free
  • Safe in patients in whom VUR fails to resolve
  • Thompson et al J Urol 2001

54
Surgery
  • Anti-reflux open procedures 95-98 success
  • Endoscopic subureteric injections 75-90 success
  • Teflon- no longer approved by FDA (success
    60-84)
  • Collagen
  • Macroplastique
  • Deflux (Dextranomer/hyaluronic acid copolymer)
    70 success
  • When?
  • Breakthrough UTI
  • Persistence of VUR
  • Parental preference

55
Treatment Bladder Retraining
  • Aims at increasing functional bladder capacity
    and reduction in residual volume
  • 2-3 hourly voiding
  • Double voiding
  • Increasing retention capacity
  • Isolated success in continence rate 35

56
Prevention
57
Breast feeding
  • Lactoferrin and oligosaccharides act as analogues
    for microbial receptors
  • Prevents mucosal attachment
  • Lactoferrin can kill bacteria, viruses and fungi

58
Prevention
  • Healthy voiding pattern
  • Avoidance of constipation
  • Avoidance of local colonization
  • Circumcision?
  • Cranberry juice?
  • Probiotics?

59
Points to remember
  • Accurate diagnosis of UTI
  • Low threshold to investigate in younger children
    (lt4 years)
  • Appropriate treatment of acute events
  • Consider other problems when managing UTI

60
Points to remember
  • The need to recognize the relationship between
  • VUR
  • Recurrent UTIs
  • Voiding dysfunction
  • Renal scarring
  • Treatment should target each factor

61
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com